Alpha 2.0
Login Register
» Authors » Megan N Kummerlowe

Megan N Kummerlowe

Explore the profile of Megan N Kummerlowe including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 54
Followers 0
Related Specialties
Oncology
Radiology
Pharmacology
Top 10 Co-Authors
Colette J Shen
Kristin J Redmond
Lawrence R Kleinberg
Daniele Rigamonti
Katherine M Moore
Hannah K Betcher
Ralph H Hruban
Michael K Lim
Matthew J Weiss
Amy Hacker-Prietz
Published In
Int J Radiat Oncol Biol Phys
Oncotarget
J Clin Psychopharmacol
Pract Radiat Oncol
Adv Radiat Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Retrospective Review of Postpartum Lithium Use Including During Lactation
Kummerlowe M, Leung J, Kummer L, Moore K, Huppert R, Betcher H
Breastfeed Med . 2024 Aug; 19(10):796-800. PMID: 39109411
Lithium remains a gold standard treatment for bipolar disorder including during peripartum. Historically, guidelines advised against breastfeeding while taking lithium though recent data suggest it is acceptable for a healthy...
2.
A First Trimester Exposure to Ketamine and Esketamine for Depression: A Case Report
Kummerlowe M, Kung S, Moore K, Betcher H
J Clin Psychopharmacol . 2024 Apr; 44(4):429-431. PMID: 38597403
No abstract available.
3.
"Super Second," a Unique, Growth-Oriented Residency Rotation Supporting Intern Integration
Park J, Kummerlowe M, Breitinger S, Allen N, Morgan R
Acad Psychiatry . 2024 Feb; 48(5):441-444. PMID: 38316657
No abstract available.
4.
Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage
Shen C, Kummerlowe M, Redmond K, Martinez-Gutierrez J, Usama S, Holdhoff M, et al.
Adv Radiat Oncol . 2018 Oct; 3(4):582-590. PMID: 30370358
Purpose: Reirradiation for recurrent glioma remains controversial without knowledge of optimal patient selection, dose, fractionation, and normal tissue tolerances. We retrospectively evaluated outcomes and toxicity after conventionally fractionated reirradiation for...
5.
A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review
Rosati L, Kummerlowe M, Poling J, Hacker-Prietz A, Narang A, Shin E, et al.
Oncotarget . 2017 Dec; 8(59):100942-100950. PMID: 29246032
Purpose: We report a very unique case of an esophageal metastasis from a pancreatic ductal adenocarcinoma (PDAC) primary. Methods: After obtaining consent from the patient, all relevant records of the...
6.
Combined modality therapy improves overall survival for angiosarcoma
Shen C, Parzuchowski A, Kummerlowe M, Morris C, Meyer C, Habibi M, et al.
Acta Oncol . 2017 Mar; 56(9):1235-1238. PMID: 28358642
No abstract available.
7.
The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring
Shen C, Rigamonti D, Redmond K, Kummerlowe M, Lim M, Kleinberg L
Pract Radiat Oncol . 2016 Oct; 6(6):409-416. PMID: 27687187
Purpose: Stereotactic radiosurgery (SRS) is widely used to treat brain metastases in place of whole brain radiation therapy (WBRT), with the goal of reducing treatment toxicity balanced against the risk...
8.
Stereotactic Radiosurgery: Treatment of Brain Metastasis Without Interruption of Systemic Therapy
Shen C, Kummerlowe M, Redmond K, Rigamonti D, Lim M, Kleinberg L
Int J Radiat Oncol Biol Phys . 2016 Apr; 95(2):735-42. PMID: 27034175
Purpose: To evaluate the prevalence, outcomes, and toxicities of concurrent delivery of systemic therapy with stereotactic radiosurgery (SRS) for treatment of brain metastases. Methods And Materials: We conducted a retrospective...